Ovarian cancer is the second-most common malignancy and the leading cause of death in women who develop cancers of gynaecologic origin and it spread primarily by direct exfoliation of cells along the peritoneal surface. Interesting fact, although not well studied, is that these tumours invade the mesothelium but very rarely they invade the peritoneum deeper through direct extension.
Aims
To study the retroperitoneal pelvic invasion in parametrial ligaments and vagina in patients undergoing surgery for advanced epithelial ovarian carcinoma and the survival impact of it.
Methods
The study included 59 patients with advanced epithelial ovarian cancer that underwent radical hysterectomy during the 2004-2009 period. For the purpose of this study histopathologic examination was performed for the parametrial ligaments and vagina with inspection of the surgical resection lines.
Results
Retroperitoneal pelvic invasion was found in 42. 4 per cent of the cases, involving different depths of parametrial ligaments and/or vaginal spread, and is associated to worse survival outcomes.
Conclusion
Retroperitoneal pelvic invasion is not a rare phenomenon and seems to be a feature of the more aggressive tumours. In the cases of distal retroperitoneal pelvic invasion (vaginal) the patients' 5-year survival rate is similar to that of the stage IV ovarian cancer patients.
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What this study adds:
What is known about this subject?
Ovarian cancer is spread primarily by direct exfoliation of cells along the peritoneal surface.
What new information is offered in this study?
Retroperitoneal pelvic invasion, involving different depths of parametrial ligaments and/or vaginal spread is more often than it is thought.
What are the implications for research, policy, or practice?
Тhis necessitates more aggressive surgical treatment in the early stages of ovarian cancer.
Background
Ovarian cancer is the second-most common malignancy and the leading cause of death in women with gynaecological cancers. The patients were divided into three groups based on the level (depth) of retroperitoneal pelvic invasion: patients without RPI, patients with only parametrial involvement and third group -with parametrial and vaginal invasion. Overall survival (OS) was evaluated and compared between the groups applying the Kaplan-Meier, Log-Rank, Breslow, and Tarone-Ware methods ( Figure 3 and Table 1 ). We found significant differences in the overall survival between the group with distal invasion in parameters and vagina and the group without RPI. Such significant difference is not observed between the groups without RPI and with only proximal involvement -of only parametria. Evaluating the 5-year survival we can see that there were no surviving patients with distal disease dissemination to the pelvic wall, as well as to the vagina ( Table 2 ). The mean overall survival was 22 months, not depending on the residual tumour size. 
Discussion
The biological "behaviour" of ovarian cancer is unique and quite different from the classical and well-studied haematogenous dissemination. 8 Ovarian cancer spreads through the following routes: peritoneal dissemination, direct extension (contact growth), lymphatic and haematogenous pathways. The most common and earliest mode of spread of the epithelial tumours is through exfoliation of cells along the peritoneal surface. 9 The exfoliated cells migrate directly towards the lesser pelvis and the abdominal peritoneal surface and likely to follow the route of spread of peritoneal fluid from the right paracolic canal towards the right hemidiaphragm. Surface implanted metastases occur in the abdominal cavity and the pelvis. Interesting, but not well-studied, is the fact that these tumours invade the mesothelium, but very rarely they invade the peritoneum deeper. 10 The vagina is covered by peritoneum in a small part of its upper quarter.
Well-known is that main factor for the successful treatment of advanced ovarian cancer is the maximal cytoreduction. The possibility of its achievement depends on the localization of metastatic disease and their operability. In 2009 FIGO had a revision and direct retroperitoneal pelvic invasion was included as a prognostic factor in the staging of cervical, endometrial and vulvar cancers. The prognostic role of RPI in epithelial ovarian cancer remains unclear.
11
The results from our study show that invasion in the retroperitoneal structures (excluding lymphatic spread) is not a rare phenomenon in advanced epithelial ovarian cancer -in 42.4 per cent of the patients, and in 16.9 per cent vaginal metastases are observed. Probably the explanation of such high percentages is due to the fact that in 59 patients were performed radical hysterectomy and our pathologists were looking in particular for retroperitoneal invasion. In one study Perreira et al., report 18.9 per cent retroperitoneal involvement unrelated to pelvic lymph nodes and very low 5-year survival of 14.3 per cent for the patients with RPI and early clinical stage (I-IIIB), while 5-year survival reported for the patients without RPI is 50 per cent. 11 The presence of hematogenous metastases at diagnosis is uncommon and is usually a late finding. Hematogenous metastases in liver and/or lungs are found in only 2 per cent to 3 per cent of the patients when diagnosed with the disease. 10 In a report by Dauplat et al., distant metastases compliant with stage IV were documented in nearly two-fifths of the patients who died from ovarian cancer initially thought to be confined to the peritoneal cavity.
